Standex's Q1 Earnings Call: Our Top 5 Analyst Questions

Standex’s first quarter results for 2025 were well received by the market, driven primarily by strong contributions from recently acquired businesses and new product launches. CEO David Dunbar noted that “sales into fast-growing end markets represented a greater percentage of total sales,” with recent acquisitions like Amran/Narayan and McStarlite adding significant momentum. Management attributed the company’s ability to maintain operating margins to a combination of price actions and productivity initiatives, despite ongoing organic revenue declines in several core segments.

Is now the time to buy SXI? Find out in our full research report (it’s free).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions Standex’s Q1 Earnings Call

• Chris Moore (CJS Securities) asked about the impact of tariffs by segment and how Standex plans to cover associated costs. CEO David Dunbar confirmed that price and productivity actions would address most impacts, except for some challenges in Scientific.
• Matt Koranda (ROTH Capital) questioned the drivers of growth at Amran/Narayan and the timeline for European expansion. Dunbar clarified that grid modernization and data centers are key, and the European plant requires limited initial investment.
• Ross Sparenblek (William Blair) inquired about the outlook for core electronics and confidence in returning to organic growth. CFO Ademir Sarcevic pointed to strengthening orders in Asia and an inflection point for organic growth in the coming quarters.
• Gary Prestopino (Barrington Research) sought clarity on fast-growth market sales and margin contributions from recent acquisitions. Dunbar emphasized that margins in these markets are higher than the company average and are becoming more accretive as they scale.
• Mike Shlisky (D.A. Davidson) probed working capital and tariff risk, with Sarcevic reiterating that overall corporate exposure to tariffs is minimal and that opportunities exist to improve cash conversion through better receivables management.

Catalysts in Upcoming Quarters

In future quarters, our analysts will be watching (1) the pace and execution of capacity expansions in India, the U.S., and Europe, (2) continued adoption rates and revenue contribution from new product launches across fast-growth markets, and (3) progress on restructuring and cost-saving initiatives in underperforming segments. We will also monitor the company’s ability to mitigate tariff impacts and adapt to funding pressures in the Scientific segment.

Standex currently trades at $157.96, up from $145.04 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).

High-Quality Stocks for All Market Conditions

Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.

While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.